Department of Ophthalmology
Sandra Johnen has not added Biography.
If you are Sandra Johnen and would like to personalize this page please email our Author Liaison for assistance.
Antiangiogenic and Neurogenic Activities of Sleeping Beauty-Mediated PEDF-Transfected RPE Cells In Vitro and In Vivo.
BioMed research international , 2015 | Pubmed ID: 26697494
Properties of Retinal Precursor Cells Grown on Vertically Aligned Multiwalled Carbon Nanotubes Generated for the Modification of Retinal Implant-Embedded Microelectrode Arrays.
Journal of ophthalmology , 2016 | Pubmed ID: 27200182
Engineering of PEDF-Expressing Primary Pigment Epithelial Cells by the SB Transposon System Delivered by pFAR4 Plasmids.
Molecular therapy. Nucleic acids Mar, 2017 | Pubmed ID: 28325297
Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side.
Critical reviews in biochemistry and molecular biology 08, 2017 | Pubmed ID: 28402189
Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery.
Molecular therapy. Nucleic acids , | Pubmed ID: 29246287
Cryopreservation of amniotic membrane with and without glycerol additive.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie Jun, 2018 | Pubmed ID: 29623460
The Antibiotic-free pFAR4 Vector Paired with the Sleeping Beauty Transposon System Mediates Efficient Transgene Delivery in Human Cells.
Molecular therapy. Nucleic acids , | Pubmed ID: 29858090
The very large electrode array for retinal stimulation (VLARS)-A concept study.
Journal of neural engineering 11, 2019 | Pubmed ID: 31480027
Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization.
Molecular therapy. Methods & clinical development , | Pubmed ID: 31890733
Establishment and Characterization of a Unilateral UV-Induced Photoreceptor Degeneration Model in the C57Bl/6J Mouse.
Translational vision science & technology 08, 2020 | Pubmed ID: 32879777
University Hospital RWTH Aachen
Sandra Johnen1,
Nina Harmening2,3,
Corinne Marie4,5,
Daniel Scherman4,
Zsuzsanna Izsvák6,
Zoltán Ivics7,
Peter Walter1,
Gabriele Thumann2,3
1Department of Ophthalmology, University Hospital RWTH Aachen,
2Experimental Ophthalmology, University of Geneva,
3Department of Ophthalmology, University Hospitals of Geneva,
4, Université de Paris, CNRS, INSERM, UTCBS, Unité des technologies Chimiques et Biologiques pour la Santé,
5Chimie ParisTech, PSL Research University,
6, Max Delbrück Center for Molecular Medicine in the Helmholtz Association,
7Division of Medical Biotechnology, Paul-Ehrlich-Institute
Thais Bascuas*,1,2,
Martina Kropp*,1,2,
Nina Harmening1,2,
Brittany M. Wong1,
Sandra Johnen3,
Zsuzsanna Izsvák4,
Gabriele Thumann1,2
1Experimental Ophthalmology, University of Geneva,
2Department of Ophthalmology, University Hospitals of Geneva,
3Department of Ophthalmology, University Hospital RWTH Aachen,
4, Max Delbrück Center for Molecular Medicine
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
Исследования
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
Образование
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены
